Sarepta Therapeutics Inc. (NASDAQ: SRPT) started the day on May 18, 2023, with a price decrease of -1.57% at $146.43. During the day, the stock rose to $149.00 and sunk to $144.36 before settling in for the price of $148.77 at the close. Taking a more long-term approach, SRPT posted a 52-week range of $61.28-$159.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 43.30%. Meanwhile, its Annual Earning per share during the time was -56.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -55.90%. This publicly-traded company’s shares outstanding now amounts to $88.19 million, simultaneously with a float of $83.68 million. The organization now has a market capitalization sitting at $13.64 billion. At the time of writing, stock’s 50-day Moving Average stood at $133.48, while the 200-day Moving Average is $121.26.
If we measure the efficiency of the company that is accounted for 1162 employees. It has generated 802,937 per worker during the last fiscal year. Meanwhile, its income per employee was -605,411. The stock had 4.33 Receivables turnover and 0.30 Total Asset turnover. For the Profitability, stocks gross margin was +80.51, operating margin was -56.83 and Pretax Margin of -73.95.
Sarepta Therapeutics Inc. (SRPT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Sarepta Therapeutics Inc.’s current insider ownership accounts for 0.20%, in contrast to 89.10% institutional ownership. According to the most recent insider trade that took place on Nov 17, this organization’s Director sold 858 shares at the rate of 109.92, making the entire transaction reach 94,311 in total value, affecting insider ownership by 6,387. Preceding that transaction, on Sep 14, Company’s Director bought 57,100 for 104.43, making the whole transaction’s value amount to 5,963,124. This particular insider is now the holder of 108,178 in total.
Sarepta Therapeutics Inc. (SRPT) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/30/2023, the organization reported -$5.86 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$1.38) by -$4.48. This company achieved a net margin of -75.40 while generating a return on equity of -107.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.47 per share during the current fiscal year.
Sarepta Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -55.90% and is forecasted to reach 4.67 in the upcoming year.
Sarepta Therapeutics Inc. (NASDAQ: SRPT) Trading Performance Indicators
Let’s observe the current performance indicators for Sarepta Therapeutics Inc. (SRPT). It’s Quick Ratio in the last reported quarter now stands at 4.30. The Stock has managed to achieve an average true range (ATR) of 7.61. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 13.98.
In the same vein, SRPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -12.69, a figure that is expected to reach -1.72 in the next quarter, and analysts are predicting that it will be 4.67 at the market close of one year from today.
Technical Analysis of Sarepta Therapeutics Inc. (SRPT)
If we take a close look at the recent performances of Sarepta Therapeutics Inc. (NASDAQ: SRPT), its last 5-days Average volume was 3.55 million that shows progress from its year to date volume of 1.51 million. During the previous 9 days, stock’s Stochastic %D was recorded 74.72% While, its Average True Range was 8.51.
Raw Stochastic average of Sarepta Therapeutics Inc. (SRPT) in the period of the previous 100 days is set at 71.10%, which indicates a major rise in contrast to 71.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 117.56% that was higher than 70.39% volatility it exhibited in the past 100-days period.
